We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

This study has been terminated.
(closed to enrollment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00577161
First Posted: December 19, 2007
Last Update Posted: September 22, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
CTI BioPharma
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)